background

Baricitinib Impurity 19

Baricitinib Impurity 19 Watermark

Baricitinib Impurity 19

SZ CAT No:CL-BRI-22
CAS No:NA
Mol.F:C15H17N7O3S
Mol.Wt.:375.4
Chemical Name:3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidine-3-carboxamide
SMILES: CC[S](=O)(=O)N1CC(C1)(n2cc(cn2)c3ncnc4[nH]ccc34)C(N)=O
Inventory Status:Custom synthesis

This impurity is related to Baricitinib Impurity 19 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.

Baricitinib Impurity 19 is used as a reference standard in analytical research. It ensures consistency of formulations.

Chemical Name:3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidine-3-carboxamide
Country of Origin: India
Product Category: Impurity Reference Standard
API NAME: Baricitinib
Molecular Formula: C15H17N7O3S
Molecular Weight: 375.4
Storage: Store in a cool, dry place.

product
Baricitinib Impurity 19
Qty: -, Pack Size: -, Total Qty: -(mg)
CAT No:CL-BRI-22
CAS No:NA
Mol.F:C15H17N7O3S
Mol.Wt:375.4
Document